Prelude Capital Management’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Prelude Capital Management’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-100,600	Closed	-$992K	–	2221
2022 Q1	$992K	Sell	100,600 -50,000	-33%	-$491K	0.03%	599
2021 Q4	$1.48M	Sell	150,600 -17,100	-10%	-$168K	0.04%	440
2021 Q3	$1.65M	Buy	167,700 +98,343	+142%	+$969K	0.04%	377
2021 Q2	$686K	Buy	69,357 +59,357	+594%	+$597K	0.02%	798
2021 Q1	$103K	Buy	+10,000	New	+$111K	﹤0.01%	1423

Other funds holding LUXA

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Wolfswood Holdings New York $2.84M AUM 30.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Prelude Capital Management's LUXA Position: Q2 2022 in Review

Prelude Capital Management sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q2 2022, closing a stake of 100,600 shares — an estimated $992K sold.

Prelude Capital Management first reported a position in LUXA in Q1 2021 and held it in 5 quarters. The position peaked at $1.65M in Q3 2021. 71 funds tracked by Wall St. Rank hold LUXA as of Q2 2022.

Prelude Capital Management reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Prelude Capital Management sold 100,600 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q2 2022, an estimated $992K.
Prelude Capital Management first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 5 quarters.
Prelude Capital Management's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $1.65M in Q3 2021.
71 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q2 2022.

Based on Prelude Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.